Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD

References

• DaviesLAngusRMCalverleyPMOral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trialLancet1999354917745646010465169
   PubMed Web of Science ®Google Scholar
• NiewoehnerDEErblandMLDeupreeRHEffect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study GroupN Engl J Med1999340251941194710379017
   PubMed Web of Science ®Google Scholar
• AaronSDVandemheenKLHebertPOutpatient oral prednisone after emergency treatment of chronic obstructive pulmonary diseaseN Engl J Med2003348262618262512826636
   PubMed Web of Science ®Google Scholar
• LeuppiJDSchuetzPBingisserRShort-term vs. conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trialJAMA2013309212223223123695200
   PubMed Web of Science ®Google Scholar
• AnthonisenNRManfredaJWarrenCPHershfieldESHardingGKNelsonNAAntibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med198710621962043492164
   PubMed Web of Science ®Google Scholar
• DanielsJMSnijdersDde GraaffCSVlaspolderFJansenHMBoersmaWGAntibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2010181215015719875685
   PubMed Web of Science ®Google Scholar
• RoedeBMBresserPPrinsJMSchellevisFVerheijTJBindelsPJReduced risk of next exacerbation and mortality associated with antibiotic use in COPDEur Respir J200933228228819047316
   PubMed Web of Science ®Google Scholar
• RothbergMBPekowPSLahtiMBrodyOSkiestDJLindenauerPKAntibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary diseaseJAMA2010303202035204220501925
   PubMed Web of Science ®Google Scholar
• MullerovaHMaselliDJLocantoreNHospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohortChest20151474999100725356881
   PubMed Web of Science ®Google Scholar
• DransfieldMTBourbeauJJonesPWOnce-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trialsLancet Respir Med20131321022324429127
   PubMed Web of Science ®Google Scholar
• WedzichaJACalverleyPMSeemungalTAThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med20081771192617916806
   PubMed Web of Science ®Google Scholar
• WiseRAAnzuetoACottonDTiotropium Respimat inhaler and the risk of death in COPDN Engl J Med2013369161491150123992515
   PubMed Web of Science ®Google Scholar
• WiseRAAnzuetoACalverleyPThe Tiotropium Safety and Performance in Respimat Trial (TIOSPIR), a large scale, randomized, controlled, parallel-group trial-design and rationaleRespir Res2013144023547660
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: 2016 Report Available from: http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/Accessed April 27, 2016
   Google Scholar
• HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• VezzoliSJonesPCorradiMPatterns of symptom change measured using the EXACT diary associated with prescription of corticosteroids or antibiotics in COPD exacerbationsEur Respir J201546Suppl 59OA1969
   Google Scholar
• WilsonRAnzuetoAMiravitllesMMoxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL resultsEur Respir J2012401172722135277
   PubMed Web of Science ®Google Scholar
• AlmagroPCalboEOchoa de EchaguenAMortality after hospitalization for COPDChest200212151441144812006426
   PubMed Web of Science ®Google Scholar
• GroenewegenKHScholsAMWoutersEFMortality and mortality-related factors after hospitalization for acute exacerbation of COPDChest2003124245946712907529
   PubMed Web of Science ®Google Scholar
• RocheNZureikMSoussanDNeukirchFPerrotinDPredictors of outcomes in COPD exacerbation cases presenting to the emergency departmentEur Respir J200832495396118508819
   PubMed Web of Science ®Google Scholar
• Toft-PetersenATorp-PedersenCWeinreichUMRasmussenBSAssisted ventilation in COPD – association between previous hospitalizations and mortalityInt J Chron Obstruct Pulmon Dis20161193594327217743
   PubMed Web of Science ®Google Scholar
• SuissaSErnstPVandemheenKLAaronSDMethodological issues in therapeutic trials of chronic obstructive pulmonary diseaseEur Respir J20083192793318216056
   PubMed Web of Science ®Google Scholar
• KewKMDiasSCatesCJLong-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysisCochrane Database Syst Rev20143CD010844
   PubMed Web of Science ®Google Scholar
• YangIAClarkeMSSimEHFongKMInhaled corticosteroids for stable chronic obstructive pulmonary diseaseCochrane Database Syst Rev20127CD002991
   PubMed Web of Science ®Google Scholar
• LlorCMoragasAMiravitllesMESAB studyUsefulness of a patient symptom diary card in the monitoring of exacerbations of chronic bronchitis and chronic obstructive pulmonary diseaseInt J Clin Pract201266771171722698424
   PubMed Web of Science ®Google Scholar
• DonaldsonGCLawMKowlessarBImpact of prolonged exacerbation recovery in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2015192894395026151174
   PubMed Web of Science ®Google Scholar
• BatemanEDRabeKFCalverleyPMRoflumilast with long-acting beta2-agonists for COPD: influence of exacerbation historyEur Respir J201138355356021737553
   PubMed Web of Science ®Google Scholar
• VogelmeierCHedererBGlaabTTiotropium versus salmeterol for the prevention of exacerbations of COPDN Engl J Med2011364121093110321428765
   PubMed Web of Science ®Google Scholar
• MartinezFJCalverleyPMGoehringUMBroseMFabbriLMRabeKFEffect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trialLancet2015385997185786625684586
   PubMed Web of Science ®Google Scholar